在心力衰竭的小鼠模型中,表观遗传调节器基因组脱甲基酶KDM5A被激活并具有病原性
bioRxiv : the preprint server for biology
|January 16, 2026
概括
组织素脱甲基酶KDM5A在心力衰竭中被重新激活. 在小鼠中删除KDM5A改善了心脏功能和存活率,确定它是心力衰竭发病的关键表观遗传调节器.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 心力衰竭涉及基因表达失调和心脏功能障碍.
- 表观遗传调节剂,如基因组脱甲基酶,与心力衰竭有关.
- 基因组5A (基因组脱甲基酶) 在心力衰竭中被重新激活,但其作用尚不清楚.
研究的目的:
- 确定KDM5A在心力衰竭中的致病作用.
- 研究KDM5A对心肌细胞基因表达和心脏功能的影响.
主要方法:
- 使用LMNA-心肌病 (LMNA-CMP) 的小鼠模型.
- 特别删除了LMNA-CMP小鼠心肌细胞中的KDM5A基因.
- 进行了转录组分析和全基因组H3K4me3分析 (CUT&RUN测试).
主要成果:
- 在LMNA-CMP小鼠中KDM5A的删除改善了心脏功能,存活率,并减少了纤维化和细胞死亡.
- 恢复了1400多个失调基因的表达,包括脂肪酸代谢和氧化酸化 (OXPHOS) 中的基因.
- 在关键的心脏转录因子和代谢调节位点 (例如,Tbx5,Esrrg) 部分恢复了H3K4me3.
结论:
- KDM5A是心肌细胞基因表达的关键表观遗传调节剂.
- KDM5A在心力衰竭的发病过程中起着机械作用.
- 准KDM5A可能为心力衰竭提供治疗策略.
相关概念视频
Histone Modification
15.9K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.9K
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Spreading of Chromatin Modifications
9.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734


